LungLife AI, Inc. (AIM:LLAI)
London
· Delayed Price · Currency is GBP · Price in GBX 2.250
-0.140 (-6.22%)
Apr 28, 2025, 2:35 PM GMT+1
LungLife AI Market Cap
LungLife AI has a market cap or net worth of 689.82 thousand as of April 28, 2025. Its market cap has decreased by -92.86% in one year.
Market Cap
689.82K
Enterprise Value
-1.22M
Revenue
22.95K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
Market Cap Chart
Since July 8, 2021, LungLife AI's market cap has decreased from 52.24M to 689.82K, a decrease of -98.68%. That is a compound annual growth rate of -67.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 689.82K | -73.53% |
| Dec 31, 2024 | 2.61M | -77.77% |
| Dec 29, 2023 | 11.72M | -45.88% |
| Dec 30, 2022 | 21.66M | -54.78% |
| Dec 31, 2021 | 47.90M | -8.29% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.27B |
| GSK plc | 56.28B |
| Haleon | 34.06B |
| Smith & Nephew | 8.68B |
| ConvaTec Group | 5.25B |
| Hikma Pharmaceuticals | 4.19B |
| HUTCHMED (China) | 1.95B |
| Oxford Nanopore Technologies | 1.14B |